Similar Articles
1361 Imaging appearance of treated hepatocellular carcinoma
1362 Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors
1363 Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis
1364 Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation
1365 Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments
1366 Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
1367 Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma
1368 Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy
1369 Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma
1370 Hepatocellular carcinoma and food contamination: Ochratoxin A as a great prompter
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA